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O B J E C T I V E S The aim of this study was to assess the plaque characteristics in culprit lesions in
diabetic patients with acute coronary syndrome (ACS).
B A C KG ROUND Data of the relationship between diabetes mellitus and plaque characteristics in
patients with ACS are lacking.
METHOD S We performed grayscale intravascular ultrasound (IVUS) analysis in 422 ACS patients and
virtual histology (VH)-IVUS in 310 ACS patients. By subgroup analysis, 112 patients with acute myocardial
infarction (AMI) with plaque ruptures also were evaluated.
R E S U L T S In the diabetic subgroup, high-sensitivity C-reactive protein (hs-CRP) was signiﬁcantly
increased (p  0.008), multivessel disease was more common (65% vs. 29%, p  0.001), and plaque
burden was greater (79.7  9.8 mm2 vs. 74.2  8.9 mm2, p  0.001). In the subgroup analysis of 112
AMI patients with plaque ruptures, the presence of multiple plaque ruptures (60% vs. 29%, p  0.001)
and thrombus (72% vs. 52%, p  0.032) were more common in diabetic group. Diabetes mellitus was
the independent predictor of hs-CRP elevation (odds ratio [OR]: 3.030, 95% conﬁdence interval [CI]: 1.204
to 7.623, p  0.019), and multiple plaque ruptures (OR: 2.984, 95% CI: 1.311 to 6.792, p  0.009) by
multivariable analysis. In 310 VH-IVUS subsets, the absolute and percent necrotic core volumes were
signiﬁcantly greater (16.9  15.1 mm3 vs. 11.5  11.4 mm3, p  0.001, and 17.3  9.4% vs. 13.7  7.5%,
p  0.001, respectively), and the presence of at least one thin-cap ﬁbroatheroma (TCFA) (60% vs. 42%,
p  0.003) and multiple TCFAs (28% vs. 11%, p  0.001) were more common in the diabetic group.
Diabetes mellitus was the only independent predictor of TCFA by multivariable analysis (OR: 2.139, 95%
CI: 1.266 to 3.613, p  0.004).
CONC L U S I O N S Diabetic patients with ACS have more plaques with characteristics of plaque
vulnerability, different composition of plaques, and have increased inﬂammatory status compared with
nondiabetic patients with ACS. (J Am Coll Cardiol Img 2009;2:339–49) © 2009 by the American College
of Cardiology Foundation
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340utopsy studies have shown that acute myocar-
dial infarction (AMI) results from spontane-
ous plaque rupture or erosion and subse-
quent thrombosis (1,2). Intravascular
ltrasound (IVUS) studies have reported culprit-
esion ruptured plaques in a varying percentage
f patients with acute coronary syndrome (ACS)
3–7). There is a strong inflammatory response to
he tissue injury that occurs during an AMI, and
laque rupture and the degree of the inflammatory
esponse might be an important determinant of the
linical outcome (8). Several studies have demon-
trated an association between elevated C-reactive
protein (CRP) levels and culprit lesion
ruptured plaques in patients with AMI
(5,7,9). C-reactive protein has emerged as
a simple tool for detecting systemic in-
flammation in patients with subsequent
coronary events (10,11). Recently, several
virtual histology (VH)-IVUS studies have
demonstrated the coronary plaque compo-
nents in patients with ACS (12–14).
In a study of sudden death due to
coronary thrombosis, Davies (15) reported
that rupture accounted for 84% of thrombi
in 134 men without diabetes and that
rupture was found in 59% in 27 women
without diabetes, whereas only 34% of
thrombi were due to rupture in 41 patients
with diabetes mellitus (men and women).
However, another pathological study
showed diabetic patients had a greater
amount of macrophage-infiltrated lipid-
rich plaques compared with nondiabetic
patients (16). This means specific IVUS
and VH-IVUS findings could be identi-
fied in diabetic patients. However, no
studies have demonstrated a relationship
between diabetes mellitus and inflamma-
tory response indicated by CRP versus
plaque characteristics, including plaque
omposition and the incidence of thin-cap fibro-
theroma (TCFA) in patients with ACS. There-
ore, the aim of this study was to assess the plaque
haracteristics using IVUS and VH-IVUS and in-
ammatory response in diabetic patients with ACS.
M E T H O D S
Patient population. We assessed the impact of dia-
betes mellitus on IVUS findings in AMI patients
with plaque ruptures. A total of 3,895 patients with
ome
und
y
y
maa first AMI were admitted to our institute from aJanuary 2001 to July 2007. We performed pre-
percutaneous coronary intervention (PCI) IVUS
within 24 h from symptom onset in 380 patients.
Of these, we identified a total of 112 patients with
plaque ruptures for the analysis: 47 were diabetics
and 65 were nondiabetic. In addition, we evaluated
the impact of diabetes mellitus on plaque compo-
sition and the incidence of TCFA by using VH-
IVUS in patients with ACS. A total of 2,250
patients with ACS were admitted to our institute
from July 2006 to March 2008. Of these, we
identified 310 patients with ACS who underwent
pre-PCI VH-IVUS of native, de novo coronary
lesion: 100 were diabetic and 210 were nondiabetic.
We excluded patients with subacute or late stent
thrombosis, totally occluded lesions, restenosis after
stenting, coronary artery bypass graft failure, factors
associated with increased risk of bleeding, severe heart
failure or cardiogenic shock, important systemic dis-
ease, or serum creatinine 2.5 mg/dl, and patients in
whom adequate IVUS images could not be obtained.
Diabetes mellitus was defined as receiving oral
hypoglycemic agents or insulin to lower blood
glucose levels or known fasting blood glucose values
of 126 mg/dl or post-prandial 2-h blood glucose
values of 200 mg/dl. The presence of unstable
angina was determined by chest pain within the
preceding 72 h with or without ST–T-wave
changes or positive cardiac biochemical markers
(creatine kinase-myocardial band or cardiac specific
troponin-I). The presence of ST-segment elevation
myocardial infarction (MI) was determined by 30
min of continuous chest pain, a new ST-segment
elevation 2 mm on at least 2 contiguous electro-
cardiographic leads, and creatine kinase-myocardial
band 3  normal. The presence of non–ST-
egment elevation MI was diagnosed by chest pain
nd a positive cardiac biochemical markers (creatine
inase-myocardial band or cardiac specific troponin-I)
ithout new ST-segment elevation. The protocol
as approved by the institutional review board.
ospital records of patients were reviewed to obtain
nformation on clinical demographics.
Laboratory analysis. Peripheral blood samples were
btained before IVUS study. The blood samples
ere centrifuged, and serum was removed and
tored at70°C until the assay could be performed.
igh-sensitivity (hs)-CRP was analyzed turbidi-
etrically with sheep antibodies against human
RP; this has been validated against the Dade-
ehring method (17). We defined elevated hs-CRP
s 0.3 mg/dl in accordance with the definitionA B B R E V I A T I O N S
A N D A C R O N YM S
ACS acute coronary syndr
AMI acute myocardial
infarction
CRP C-reactive protein
SA cross-sectional area
C dense calcium
EM external elastic
embrane
F fibro-fatty
FT fibrotic
hs-CRP high-sensitivity
C-reactive protein
IVUS intravascular ultraso
MImyocardial infarction
NC necrotic core
OR odds ratio
P&M plaque plus media
PCI percutaneous coronar
intervention
QCA quantitative coronar
angiography
TCFA thin-cap fibroatherodopted elsewhere (5). Absolute creatine kinase-
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341myocardial band levels were determined by radioim-
munoassay (Dade Behring Inc., Miami, Florida).
Cardiac-specific troponin I levels were measured
with the use of paramagnetic particles and a chemi-
luminescent immunoenzymatic assay (Beckman
Coulter Inc., Fullerton, California). The serum
levels of total cholesterol, triglyceride, low-density
lipoprotein cholesterol, and high-density lipopro-
tein cholesterol were measured by the use of stan-
dard enzymatic methods.
Quantitative coronary angiography (QCA) analysis.
The location of the target coronary lesion was desig-
nated as ostial, proximal, middle, and distal. We
performed offline QCA analysis. Coronary angiogram
was analyzed with validated QCA system (Phillips
H5000 or Allura DCI program, Philips Medical
Systems, Eindhoven, the Netherlands). With the
outer diameter of the contrast-filled catheter as the
calibration standard, the minimal lumen diameter and
reference diameter were measured in diastolic frames
from orthogonal projections.
Imaging and analysis using IVUS. All IVUS exami-
ations were performed before PCI after intra-
oronary administration of 300 g of nitroglycerin
using a commercially available IVUS system (Bos-
ton Scientific Corporation/SCIMed, Minneapolis,
Minnesota). Pre-PCI VH-IVUS examinations
were performed with the use of a 20-MHz, 2.9-F
IVUS imaging catheter (Eagle Eye, Volcano Corp.,
Rancho Cordova, California). The IVUS catheter
was advanced 10 mm beyond the lesion; and
automated pullback was performed to a point 10
mm proximal to the lesion at a speed of 0.5 mm/s.
Grayscale IVUS and VH-IVUS data were ana-
lyzed by 2 independent observers (H.Y.J and
C.Y.H). The levels of reproducibility for external
elastic membrane (EEM), lumen, and plaque plus
media (P&M) cross-sectional areas (CSAs) using
the Spearman rank-order correlation coefficients
were 0.95, 0.97, and 0.97, respectively. Similarly,
for plaque components by VH-IVUS, reproducibil-
ity for the fibrous, fibro-fatty, dense calcium, and
necrotic core volume measurements using the
Spearman rank-order correlation coefficients were
0.95, 0.92, 0.93, and 0.93, respectively.
Grayscale IVUS analysis was performed accord-
ing to the American College of Cardiology Clinical
Expert Consensus Document on Standards for
Acquisition, Measurement and Reporting of Intra-
vascular Ultrasound Studies (18). At the reference
and minimum lumen sites, we measured EEM and
lumen CSA. We calculated P&M CSA as EEM
CSA minus lumen CSA, and plaque burden was tcalculated as P&M CSA divided by EEM CSA.
Coronary artery remodeling was assessed by com-
paring the lesion site to the reference EEM CSA.
Remodeling index was the minimum lumen site
EEM CSA divided by the average of the proximal
and distal reference EEM CSA. Positive remodel-
ing was defined as a remodeling index 1.05,
intermediate remodeling as a remodeling index
between 0.95 and 1.05, and negative remodeling as
a remodeling index 0.95 (19).
Hypoechoic plaque was less bright compared
with the reference adventitia. Hyperechoic, noncal-
cified plaque was as bright as or brighter than the
reference adventitia without acoustic shadowing.
Hyperechoic, calcified plaque was hyperechoic with
acoustic shadowing. A calcified lesion contained
90° of circumferential lesion calcium. When there
was no dominant plaque composition, the plaque
was classified as mixed. A ruptured plaque con-
tained a cavity that communicated with the lumen
with an overlying residual fibrous cap fragment. A
fragmented and loosely adherent plaque without a
distinct cavity and without a fibrous cap fragment
was not considered a plaque rupture. Rupture sites
separated by a length of artery containing smooth
lumen contours without cavities were considered to
represent different plaque ruptures (multiple plaque
ruptures) (20,21). Plaque cavity was measured and
extrapolated to the ruptured capsule area. Throm-
bus was an intraluminal mass having a layered or
lobulated appearance, evidence of blood flow (mi-
crochannels) within the mass, and speckling or
scintillation (Fig. 1) (21,22).
We performed VH-IVUS analyses across the
entire lesion segment (volumetric analysis), and
cross-sectional analysis was performed at the min-
imum lumen sites, at the largest necrotic core (NC)
sites, and at the reference sites. With VH-IVUS
analysis, we classified the color-coded tissue into 4
major components: green (fibrotic, FT); yellow-
green (fibro-fatty, FF); white (dense calcium, DC);
and red (NC) (12,23). We reported VH-IVUS
analysis in absolute amounts and as a percentage of
plaque area or volume. We defined TCFA as a NC
10% of plaque area in at least 3 consecutive
frames without overlying fibrous tissue in the pres-
ence of 40% plaque burden (Fig. 2) (12).
No-reﬂow and stent thrombosis. We evaluated the
ncidences of post-stenting no-reflow (post-PCI
hrombolysis In Myocardial Infarction [TIMI]
ow grade 0, 1, and 2) and acute (24 h after stent
mplantation) and subacute stent thromboses (be-
ween 1 day and 30 days after stent implantation).
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342Statistical analysis. The statistical Package for Social
ciences (SPSS) for Windows, version 15.0 (SPSS,
hicago, Illinois) was used for all analyses. Contin-
ous variables were presented as the mean value 
SD; comparisons were conducted by Student t
est or nonparametric Wilcoxon test for violations
f assumptions of normality or heterogeneity. Dis-
rete variables were presented as percentages and
elative frequencies; comparisons were conducted
y chi-square statistics or the Fisher exact test as
ppropriate. Multivariable logistic regression anal-
ses were performed to identify independent pre-
ictors of hs-CRP elevation, multiple plaque rup-
ures, and TCFA. Univariable analyses were first
onducted to identify potential risk factors for
s-CRP elevation, multiple plaque ruptures, and
CFA. The likelihood ratio test was used, and the
ariables with a p value of 0.2 were included in
he multivariable model. Finally, a stepwise logistic
egression was performed. The least significant
ariable was dropped at each step until only covari-
tes with p  0.05 remained; p  0.05 was con-
idered statistically significant.
R E S U L T S
Patient characteristics. The baseline characteristics are
ummarized in Table 1. There was a female predom-
Ruptured Plaque Cavity, Residual Fibrous Cap, and
ng Thrombus
le of ruptured plaque cavity, residual ﬁbrous cap, and surrounding
in 71-year-old diabetic patient presented with non–ST-segment
yocardial infarction. A ruptured plaque contained a cavity that
ated with the lumen with an overlying residual ﬁbrous cap frag-
ture sites separated by a length of artery containing smooth
tours without cavities were considered to represent different
tures (multiple plaque ruptures). Thrombus was an intraluminal
g a layered or lobulated appearance, evidence of blood ﬂows
nels) within the mass, and speckling or scintillation.nance in diabetic group. Diabetic patients had more
ypertension and more family history of coronary
rtery disease compared with nondiabetic patients.
iabetic patients had lower ejection fraction and
emoglobin levels, and higher triglyceride and hs-
RP levels compared with nondiabetic patients.
Angiographic and procedural results. Angiographic
ndings are summarized in Table 2. There were no
ignificant differences in culprit lesion distribution,
esion location, TIMI flow grade, reference diame-
er, minimal lumen diameter, and percent diameter
Figure 2. Images of TCFA
Grayscale intravascular ultrasound (IVUS) (A) and virtual histology
(VH)-IVUS (B) images of thin-cap ﬁbroatheroma (TCFA). We used
VH-IVUS to classify the color-coded tissue into 4 major compo-
nents: green (ﬁbrotic); yellow-green (ﬁbro-fatty); white (dense cal-
cium); and red (necrotic core). We deﬁned TCFA as a necrotic core
10% of plaque area in at least 3 consecutive frames without
overlying ﬁbrous tissue in the presence of 40% plaque burden.
Grayscale IVUS showed the large amount of heterogeneous plaque
(A), VH-IVUS showed a necrotic core-rich plaque without evidence
of ﬁbrous cap (TCFA) (B).Figure 1.
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343more frequently in diabetic patients compared with
nondiabetic patients (65% vs. 29%, p  0.001).
In subgroup analysis of 112 patients with AMI with
plaque ruptures, the presence of angiographic plaque
rupture (35 of 47 [75%] vs. 36 of 65 [55%], p 
0.039), and thrombus appearances (21 of 47 [45%] vs.
17 of 65 [26%], p  0.041) were more common in
iabetic patients compared with nondiabetic patients.
o-reflow was observed in 17% (8 of 47) in diabetic
atients and 8% (5 of 65) in nondiabetic patients (p
.13). The incidences of acute stent thrombosis (1 of
7 [2%] vs. 0 of 65 [0%], p 0.2) and subacute stent
hrombosis (3 of 47 [6%] vs. 2 of 65 [3%], p  0.4)
ere not significantly different between diabetic pa-
ients and nondiabetic patients.
Results of IVUS and VH-IVUS. Grayscale IVUS find-
ings are summarized in Table 3. Proximal and distal
reference segment lumen areas were significantly
smaller in diabetic patients compared with nondia-
Table 1. Baseline Characteristics
Diabetic
Patients
(n  147)
Nondiabetic
Patients
(n  275) p Value
Age (yrs) 65 10 64 13 0.4
Male sex 68 (46) 168 (61) 0.003
Clinical presentation 0.8
Unstable angina 80 (54) 154 (56)
Non–ST-segment
elevation MI
37 (25) 61 (22)
ST-segment
elevation MI
30 (20) 60 (22)
Hypertension 121 (82) 162 (59) 0.001
Smoking 51 (35) 105 (38) 0.5
Family history of coronary
artery disease
39 (27) 40 (15) 0.003
Chest pain to coronary
angiogram (h)
12.5 7.6 13.5 8.6 0.3
Ejection fraction (%) 54 11 59 13 0.001
White blood cells (/mm3) 8,420 3,459 7,912 2,704 0.15
Hemoglobin (g/dl) 12.2 2.2 13.4 1.6 0.001
Platelet count (103/mm3) 228 75 239 119 0.5
Creatinine (mg/dl) 1.7 1.7 1.1 0.7 0.001
Glucose (mg/dl) 177 71 120 35 0.001
Creatine kinase-
myocardial band (U/l)
15.8 42.7 14.9 28.8 0.8
Cardiac troponin-I (ng/ml) 7.8 28.1 7.8 28.4 1.0
Total cholesterol (mg/dl) 174 58 173 43 0.8
Triglyceride (mg/dl) 124 64 103 51 0.002
LDL cholesterol (mg/dl) 108 50 108 40 0.9
HDL cholesterol (mg/dl) 47 15 44 10 0.096
hs-CRP (mg/dl) 2.6 3.8 0.6 1.4 0.008
Data are presented as the n (%) of patients or mean  SD.
HDL  high-density lipoprotein; hs-CRP  high-sensitivity C-reactive pro-
tein; LDL  low-density lipoprotein; MI  myocardial infarction.betic patients. At the minimum lumen sites, lumenarea was significantly smaller and plaque burden
was significantly greater in diabetic patients com-
pared with nondiabetic patients. There were no
significant differences in IVUS lesion length, plaque
morphology, and remodeling pattern between the 2
groups.
In a subgroup analysis of 112 patients with AMI
and plaque ruptures, multiple plaque ruptures and
thrombus were observed more frequently in diabetic
patients compared with nondiabetic patients (Fig.
3). Plaque cavity area was significantly greater and
ruptured plaque length was significantly longer in
diabetic patients compared with nondiabetic pa-
tients (Fig. 4). There were no significant differences
in the incidences of multiple plaque ruptures (43%
vs. 41%, p  0.9) and thrombus (64% vs. 57%, p 
0.5) between patients with ST-segment elevation
MI and patients with non–ST-segment elevation
MI. We found that hs-CRP levels were signifi-
cantly greater in patients with multiple plaque
ruptures compared with patients without multiple
plaque ruptures (5.9  4.9 mg/dl vs. 1.8  3.2
mg/dl, p  0.002) and also was significantly greater
Table 2. Coronary Angiographic Findings
Diabetic
Patients
(n  147)
Nondiabetic
Patients
(n  275) p Value
Culprit lesion 0.5
LAD 63 (43) 132 (48)
LCX 31 (21) 59 (22)
RCA 53 (36) 84 (31)
Lesion location 0.13
Ostium 10 (7) 17 (6)
Proximal 45 (31) 108 (39)
Middle 74 (50) 107 (39)
Distal 18 (12) 43 (16)
Diseased vessel
number
0.001
1 51 (35) 197 (72)
2 52 (35) 52 (19)
3 44 (30) 26 (10)
TIMI ﬂow grade 0.4
0 0 (0) 0 (0)
1 21 (14) 30 (11)
2 34 (23) 56 (20)
3 92 (63) 189 (69)
Reference diameter
(mm)
3.17  0.79 3.23  0.78 0.2
MLD (mm) 0.62  0.30 0.68  0.52 0.3
Percent diameter
stenosis (%)
80.4  14.2 78.9  16.3 0.8
Data are presented as the n (%) of patients or mean  SD.
LAD  left anterior descending artery; LCX  left circumﬂex artery; MLD 
minimal lumen diameter; RCA  right coronary artery; TIMI  Thrombolysis
In Myocardial Infarction.
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344in patients with IVUS-detected thrombus com-
pared with patients without thrombus (3.9  4.9
mg/dl vs. 1.9  1.5 mg/dl, p  0.022) (Fig. 5).
In subgroup analysis of 310 VH-IVUS subset, at
the minimum lumen sites, the absolute and percent
NC and DC areas were significantly greater in
diabetic patients compared with nondiabetic pa-
tients; conversely, percent FT area was significantly
smaller in diabetic patients compared with nondia-
betic patients (Fig. 6). At the largest NC sites, the
absolute and percent NC and DC areas were
significantly greater in diabetic patients compared
with nondiabetic patients (NC areas: 1.85  0.92
m2 vs. 1.14  0.83 mm2, p  0.001, 30.1 
11.0% vs. 20.4 9.6%, p 0.001, respectively; and
DC areas: 0.92  0.63 mm2 vs. 0.53  0.54 mm2,
 0.001, 14.3  7.9% vs. 10.9  10.4%, p 
.037, respectively); conversely percent FT and FF
reas were significantly smaller in diabetic patients
ompared with nondiabetic patients (47.6  11.2%
s. 58.0  11.5%, p  0.001, and 7.8  6.8% vs.
Table 3. Intravascular Ultrasound Findings
Diabetic
Patients
(n  147)
Nondiabetic
Patients
(n  275) p Value
Reference
EEM CSA (mm2) 16.2 5.4 18.2 5.9 0.002
Lumen CSA (mm2) 10.0 3.3 11.6 4.1 0.001
P&M CSA (mm2) 6.2 3.3 6.7 3.1 0.2
Plaque burden (%) 38.3 10.7 37.2 11.4 0.4
Minimum lumen site
EEM CSA (mm2) 14.8 5.1 15.1 4.8 0.19
Lumen CSA (mm2) 3.0 2.2 3.9 2.5 0.018
P&M CSA (mm2) 11.8 4.5 11.2 3.6 0.15
Plaque burden (%) 79.7 9.8 74.2 8.9 0.001
IVUS lesion length (mm) 20.6 11.2 19.9 11.1 0.2
Distal reference
EEM CSA (mm2) 13.9 5.4 14.7 5.5 0.2
Lumen CSA (mm2) 8.3 3.7 9.2 3.3 0.021
P&M CSA (mm2) 5.7 2.6 5.6 3.1 0.8
Plaque burden (%) 40.2 10.6 36.6 11.1 0.004
Plaque morphology 0.12
Hypoechoic 91 (62) 165 (60)
Hyperechoic, noncalciﬁed 22 (15) 53 (19)
Hyperechoic, calciﬁed 27 (18) 33 (12)
Mixed 7 (5) 24 (9)
Remodeling pattern 0.12
Positive remodeling 47 (32) 75 (27)
Intermediate remodeling 40 (27) 59 (22)
Negative remodeling 60 (41) 141 (51)
Data are presented as the n (%) of patients or mean  SD.
EEM  external elastic membrane; CSA  cross-sectional area; P&M 
plaque plus media; IVUS  intravascular ultrasound.1.3 9.2%, p 0.007, respectively). The absolutend percent NC and DC volumes were significantly
reater in diabetic patients compared with nondia-
etic patients; conversely, percent FT and FF vol-
mes were significantly smaller in diabetic patients
ompared with nondiabetic patients (Fig. 7). The
ercent NC area at the proximal reference sites
11.6  11.3% vs. 8.8  8.5%, p  0.041) and the
ercent NC and DC areas at the distal reference
ites (12.9  13.4% vs. 8.5  10.2%, p  0.009,
nd 8.3  11.7% vs. 2.6  4.4%, p  0.001,
espectively) were significantly greater in diabetic
atients compared with nondiabetic patients. At
east one TCFA and multiple TCFAs were ob-
erved more frequently in diabetic patients com-
ared with nondiabetic patients (Fig. 8).
Multiple Plaque Ruptures
IVUS-Detected Thrombus
p=0.001
p=0.032
Diabetics  (n=47)
Non-diabetics (n=65)
Diabetics (n=47)
Non-diabetics (n=65)
60
29
80
60
40
20
 0
80
60
40
20
 0
72
52
%
%
A
B
Figure 3. The Incidences of Multiple Plaque Ruptures and
Thrombus
The incidences of multiple plaque ruptures (A) and intravascular
ultrasound (IVUS)-detected thrombus (B) in 112 patients with
acute myocardial infarction with plaque ruptures. A ruptured
plaque contained a cavity that communicated with the lumen
with an overlying residual ﬁbrous cap fragment. Rupture sites
separated by a length of artery containing smooth lumen con-
tours without cavities were considered to represent different
plaque ruptures (multiple plaque ruptures). Thrombus was an
intraluminal mass having a layered or lobulated appearance,
evidence of blood ﬂow (microchannels) within the mass, and
speckling or scintillation. Multiple plaque ruptures (A) and
thrombus (B) were observed more frequently in diabetic
patients compared with nondiabetic patients.
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345Independent predictors of hs-CRP elevation, multiple
plaque ruptures, and TCFA. In a subgroup analysis of
112 patients with AMI with plaque ruptures, we
performed multivariate analysis to determine inde-
pendent predictors of hs-CRP elevation. The fol-
lowing variables were tested (all with p  0.2 in
univariable analysis): diabetes mellitus, smoking,
ejection fraction, initial diagnosis, positive remod-
eling, soft plaque, minimum lumen site plaque
burden, IVUS-detected thrombus, and IVUS-
detected multiple plaque ruptures. Diabetes melli-
tus (odds ratio [OR]: 3.030, 95% confidence inter-
val [CI]: 1.204 to 7.623, p  0.019), IVUS-
etected multiple plaque ruptures (OR: 6.305, 95%
I: 2.612 to 15.220, p  0.001), and IVUS-
etected thrombus (OR: 3.178, 95% CI: 1.134 to
.911, p  0.028) were the independent predictors
f hs-CRP elevation. Multivariable analysis deter-
ined independent predictors of multiple plaque
uptures to be diabetes mellitus, age, smoking,
nitial diagnosis, positive remodeling, soft plaque,
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Figure 4. The Plaque Cavity Area and Ruptured Plaque Length
The plaque cavity area (A) and ruptured plaque length (B) in
112 patients with acute myocardial infarction with plaque rup-
tures. A ruptured plaque contained a cavity that communicated
with the lumen with an overlying residual ﬁbrous cap fragment.
Plaque cavity was measured and extrapolated to the ruptured
capsule area. Plaque cavity area was signiﬁcantly greater in dia-
betic patients compared with nondiabetic patients (A). Ruptured
plaque length was signiﬁcantly longer in diabetic patients com-
pared with nondiabetic patients (B).s-CRP, and minimum lumen site plaque burdenall with p  0.2 in univariable analysis). Diabetes
ellitus was the only independent predictor of
ultiple plaque ruptures (OR: 2.984, 95% CI:
.311 to 6.792, p  0.009), and hs-CRP ap-
roached significance (OR: 1.013, 95% CI: 0.999 to
.026, p  0.061).
In VH-IVUS subset, multivariable analysis de-
ermined independent predictors of TCFA to be
ge, male sex, diabetes mellitus, hypertension,
moking, ejection fraction, hs-CRP, and minimum
umen site plaque burden (all with p  0.2 in
nivariable analysis). Diabetes mellitus was the only
ndependent predictor of TCFA (OR: 2.139, 95%
I: 1.266 to 3.613, p  0.004).
D I S C U S S I O N
Diabetic patients had more plaques, which ap-
peared to have characteristics of plaque vulnerability
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Figure 5. The hsCRP Levels
The high-sensitivity C-reactive protein (hs-CRP) levels according
to the presence/absence of multiple plaque ruptures (A) and
according to the presence/absence of intravascular ultrasound-
detected thrombus (B) in 112 patients with acute myocardial
infarction with plaque ruptures. We analyzed hs-CRP turbidimet-
rically with sheep antibodies against human CRP; this has been
validated against the Dade-Behring method. We found that hs-
CRP levels were signiﬁcantly greater in patients with multiple
plaque ruptures compared with patients without multiple
plaque ruptures (A) and also were signiﬁcantly greater in
patients with intravascular ultrasound-detected thrombus com-
pared with patients without intravascular ultrasound-detected
thrombus (B).
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346and a different composition of plaques than nondi-
abetic patients for those presenting with ACS. We
found that hs-CRP levels were significantly higher
in diabetic ACS patients compared with nondia-
betic ACS patients. In AMI patients with plaque
rupture, multiple plaque ruptures and thrombus
were observed more frequently in diabetic patients
compared with nondiabetic patients, and diabetes
mellitus was an independent predictor of hs-CRP
elevation and multiple plaque ruptures. In VH-
IVUS subset, the NC-containing plaque was sig-
nificantly greater, TCFAs were observed more fre-
quently in diabetic patients compared with
nondiabetic patients, and diabetes mellitus was an
independent predictor of TCFA.
Pathological studies have demonstrated that
plaque rupture and subsequent thrombosis is the
most important mechanism leading to an ACS
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Figure 6. The Absolute and Relative Plaque Areas at the
Minimum Lumen Sites
The absolute (A) and relative (B) plaque areas at the minimum
lumen sites in 310 virtual histology-intravascular ultrasound (VH-
IVUS) subset. We used VH-IVUS to classify the color-coded tissue
into 4 major components: green (ﬁbrotic, FT); yellow-green
(ﬁbro-fatty, FF); white (dense calcium, DC); and red (necrotic
core, NC). The absolute NC and DC areas and percent NC and
DC areas were signiﬁcantly greater in diabetic patients com-
pared with nondiabetic patients; conversely, percent FT area
was signiﬁcantly smaller in diabetic patients compared with
nondiabetic patients.(1,2). Previous grayscale IVUS studies have re-ported varying frequencies of infarct-related artery
plaque rupture in patients with AMI (3–7). Several
VH-IVUS studies have reported that ACS patients
had more TCFAs compared with stable angina
patients (12,13). Morbidity and mortality in dia-
betic patients is markedly greater compared with
nondiabetic patients (24,25). This greater event rate
in diabetic patients may be associated with abnor-
malities in endothelial and vascular smooth muscle
cell function, as well as a propensity to thrombosis,
which contribute to atherosclerosis and its compli-
cations (26–28).
Plaque composition may play a role in the plaque
disruption and thrombosis that leads to acute cor-
onary events (29–32). Lesions with a large lipid
core may have a greater risk for disruption than
sclerotic plaques (32–34). In the study by Moreno
et al. (16), the incidence of coronary thrombosis was
greater in atherectomy specimens from patients
140
120
100
80
60
40
20
0
80
70
60
50
40
30
20
10
0
(%
)
(m
m
 )3
63.758.7
18.619.7
9.8 5.4
16.9
11.5
58
61.3
15.1
18.5
9.5
6.6
17.3
13.7
FT         FF        DC         NC
%FT    %FF    %DC   %NC
Diabetics(n=100)
Non-diabetics(n=210)
Diabetics(n=100)
Non-diabetics(n=210)
p<0.001
p<0.001
p<0.001
p<0.001
p=0.003
p=0.004
p=0.5
p=0.7
A
B
Absolute Plaque Volume
Relative Plaque Volume
Figure 7. The Volumetric Absolute and Relative Plaque
Components
The volumetric absolute (A) and relative (B) plaque components
in 310 virtual histology-intravascular ultrasound (VH-IVUS) sub-
set. We used VH-IVUS to classify the color-coded tissue into 4
major components: green (ﬁbrotic, FT); yellow-green (ﬁbro-fatty,
FF); white (dense calcium, DC); and red (necrotic core, NC). The
absolute NC and DC volumes and percent NC and DC volumes
were signiﬁcantly greater in diabetic patients compared with
nondiabetic patients; conversely, percent FT and FF volumes
were signiﬁcantly smaller in diabetic patients compared with
nondiabetic patients.
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347with diabetes mellitus compared with patients with-
out diabetes mellitus. This finding is in agreement
with the study of Silva et al. (31), who found an
increased incidence of coronary thrombosis docu-
mented by angioscopy in diabetic patients with
unstable angina. In the present study which in-
cluded AMI patients with plaque rupture, the
incidences of multiple plaque ruptures and throm-
bus were 60% and 72% in diabetic patients, respec-
tively, which were greater than those of nondiabetic
patients (29% and 52%, respectively).
Thin-cap fibroatheroma is the precursor of
plaque rupture, which accounts for a majority of
coronary thrombi and coronary death (29,35,36).
Previous pathological study showed diabetic pa-
tients had a larger content of lipid-rich plaque
compared with nondiabetic patients (16). One au-
topsy study reported inflammation and NC size
play a greater role in the progression of atheroscle-
rosis in diabetic subjects in sudden coronary death
(37). This result suggests that diabetic patients have
a greater probability of vulnerable plaque (TCFA,
plaque rupture, and thrombus), which can lead to
acute coronary events. Nasu et al. (38) reported that
the prevalence of TCFA in target vessels of diabetic
stable angina patients was significantly greater than
in nondiabetic stable angina patients. In their VH-
IVUS study for nonculprit vessel, Valgimigli et al.
(39) reported that distance from the ostium to the
TCFA
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Figure 8. The Incidence of Culprit Lesion TCFA
The incidence of culprit lesion TCFA in 310 VH-IVUS subset. We
used VH-IVUS to classify the color-coded tissue into 4 major
components: green (ﬁbrotic); yellow-green (ﬁbro-fatty); white
(dense calcium); and red (necrotic core). We deﬁned TCFA as a
necrotic core 10% of plaque area in at least 3 consecutive
frames without overlying ﬁbrous tissue in the presence of 40%
plaque burden. The presence of at least one TCFA and multiple
TCFAs within culprit lesions were observed more frequently in
diabetic patients (brown bars) compared with nondiabetic
patients (orange bars). Abbreviations as in Figure 2.plaque was an independent predictor of relative alipid content, as well as older age, unstable presen-
tation, no use of statin, and presence of diabetes
mellitus.
Unlike the study by Nasu et al. (38) and Valgi-
migli et al. (39), we assessed the plaque components
and the incidence of TCFA in diabetic ACS
patients. The present study showed that diabetic
ACS patients had more NC-containing lesions at
the reference sites as well as at the culprit lesion
sites and had more TCFAs compared with nondi-
abetic ACS patients. Thus, diabetic patients may
have a high risk of plaque rupture and thrombus
formation, which can lead to MI and cardiac death,
because of the disruption of TCFA, and more
post-intervention problems such as edge stenoses
and dissections. Therefore, the recognition of NC
burden and the presence of TCFA by VH-IVUS
may be important in regard to improve the prog-
nosis of diabetic ACS patients.
Several IVUS studies have demonstrated an as-
sociation between increased CRP levels and culprit
lesion plaque ruptures in AMI patients (5,7,10).
Sano et al. (5) reported that more plaque ruptures
were observed in AMI patients with increased CRP
levels than in AMI patients with a normal CRP
levels. Hong et al. (7) reported that the only
independent predictor of plaque rupture in AMI
patients was an elevated CRP level in their 3-vessel
IVUS study. Tanaka et al. (10) reported that AMI
patients with culprit lesion plaque ruptures pre-
sented with greater CRP levels as compared with
AMI patients without plaque rupture. In the
present study, hs-CRP levels were significantly
greater in diabetic AMI patients with plaque rup-
ture compared with nondiabetic AMI patients with
plaque rupture (4.6  3.2 mg/dl vs. 2.4  2.1
mg/dl, p  0.005), and hs-CRP levels were signif-
icantly greater in patients with multiple plaque
ruptures or IVUS-detected thrombus compared
with patients without multiple plaque ruptures or
thrombus. The results of the present study are
consistent with those of previous studies.
Study limitations. First, the study population was
elatively small. Second, IVUS and VH-IVUS im-
ging were performed at the discretion of the
ndividual operators, leading to potential selection
ias. Third, the analyses were retrospective and are
ubject to limitations inherent in this type of clinical
nvestigation. Fourth, we did not perform 3-vessel
VUS and VH-IVUS. Therefore, we did not assess
he frequency of noninfarct-related artery plaque
uptures or thrombus and nonculprit site TCFAs,
nd we did not demonstrate the relationship be-
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348tween multivessel plaque ruptures or thrombus and
multivessel TCFAs vs. clinical events. Fifth, we did
not attempt to differentiate between atherosclerotic
plaque and thrombus because VH-IVUS could not
determine the presence of thrombus, a finding that
may obscure the identification of TCFA. Sixth,
because the CRP level was not measured serially
after AMI, it cannot be ascertained whether the
CRP elevations were the result or the cause of the
plaque rupture or thrombus. Seventh, heavily calci-
fied plaques may induce an artifact regarding the
codification of plaques by VH-IVUS resulting in an
increase in NC content. This remains a potential
limitation of the present VH study. Eighth, because
we excluded the patients with serious conditions
like totally occluded coronary lesions, increased risk
of bleeding, severe heart failure, cardiogenic shock,
important systemic disease, or renal dysfunction,
the present study might not reflect the true spec-vessel intravascular ultrasound study
1
1
1
1
1
Necrotic core and
calcium are predictopercentage of NC in untested ACS populations.
Ninth, this report was exploratory and that direct
associations cannot be inferred from the analysis.
C O N C L U S I O N S
Diabetic patients with ACS have more plaques and
have characteristics of plaque vulnerability and a
different composition of plaques and greater inflam-
matory status compared with nondiabetic ACS
patients. The IVUS features of vascular disease
consistent with plaque vulnerability and rupture are
more prevalent in diabetics likely due to the type of
vascular involvement in this diffuse disease.
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